Obesity

Question 1

Phentermine, diethylpropion, and phendimetrazine all release

Answer 1

NE

Question 2

Not for use in HTN and heart disease. Decrease appeptite

Answer 2

Amephetamine like

Question 3

Malabsorbs fat. Gastric and pancreatic lipase inhibitor

Answer 3

Orlistat

Question 4

Decreases appetite. Selective 5HT2c agonist increasing serotonin

Answer 4

Lorcaserin

Question 5

Decreases appetite. NE, GABA

Answer 5

Phentermine/topiramate

Question 6

Decreases appetite. Opioid antagonist. Dopamine and NE

Answer 6

Naltrexone/buproprion

Question 7

Decreases appetite. Shot. Glucagon like peptide (GLP-1) receptor agonist

Answer 7

Liraglutide

Question 8

Malabsorption of fat > diarrhea and incontinence.

Severe liver impairment and death. Safer for CV, HTN, diabetes than amphetamine like drugs

Answer 8

Orlistat

Question 9

Schedule 4 (potential for abuse). Can cause serotonin syndrome, neuroleptic malignant syndrome, and valvular heart disease. Cognitive impairment and euphoria. Safer for HTN and CV.

Answer 9

Locaserin

Question 10

Schedule 4 (potential for abuse). Increases HR, insomnia, suicidal ideation, paresthesias, dizziness, constipation, dry mouth, dysgeusia (food tastes bad), psychos, and cognitive impairment

Answer 10

Phentermine/topiramate

Question 11

Dysgeusia means

Answer 11

Food tastes bad

Question 12

Avoid phentermine/topiramate in

Answer 12

HTN or CVD

Question 13

Avoid naltrexone/bupropion if patient is taking

Answer 13

Narcotics

Question 14

Black box warning for naltrexone/bupropion is for

Answer 14

Suicidal thoughts

Question 15

Most expensive med. Risk for colon cancer and thyroid cancer

Answer 15

Liraglutide

Question 16

Only drugs that aren’t approved for long term use. Only approved for use for 3 months b/c of their side effects

Answer 16

Amphetamine like drugs

Question 17

Phentermine, diethylpropion, phendimetrazine

Answer 17

Amphetamine like